Literature DB >> 8134009

Management and outcome of low-grade astrocytomas of the midline in children: a retrospective review.

H J Hoffman1, D S Soloniuk, R P Humphreys, J M Drake, L E Becker, B O De Lima, J H Piatt.   

Abstract

Low-grade astrocytomas of the midline of the brain can be difficult to manage because of their location. To evaluate treatment and outcome, we performed a retrospective study of children with midline low-grade astrocytomas admitted to The Hospital for Sick Children between 1976 and 1991. Eighty-eight children with biopsy-proven low-grade astrocytomas were identified. Forty-three tumors occurred in the optic pathways or hypothalamus, 13 in the thalamus, 7 in the pineal region, 14 in the midbrain, and 11 in the medulla. Patient follow-up ranged from 6 months to 15 years, with a mean of 4 years, 9 months. Overall outcome was related to the extent of resection, histological type, and location. Partial resections were often associated with involution of the tumor. Response to radiation was variable, and serious sequelae were observed. Thirty-three patients experienced recurrence, often with a good response to subsequent surgery; however, 12 of these patients died. The probability of survival was calculated to be 96% at 1 year, 91% at 5, and 80% at 10 years. Our study suggests that resection should be considered in all patients, both at presentation and recurrence.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8134009     DOI: 10.1227/00006123-199312000-00002

Source DB:  PubMed          Journal:  Neurosurgery        ISSN: 0148-396X            Impact factor:   4.654


  26 in total

1.  Proton magnetic resonance spectroscopic imaging of pediatric low-grade astrocytomas.

Authors:  J A Lazareff; C Olmstead; K H Bockhorst; J R Alger
Journal:  Childs Nerv Syst       Date:  1996-03       Impact factor: 1.475

2.  Neurofibromatosis 1-associated optic pathway gliomas.

Authors:  Ben Shofty; Liat Ben Sira; Shlomi Constantini
Journal:  Childs Nerv Syst       Date:  2020-06-11       Impact factor: 1.475

3.  Optic pathway glioma in children: does visual deficit correlate with radiology in focal exophytic lesions?

Authors:  Kristian Aquilina; David J Daniels; Helen Spoudeas; Kim Phipps; Hoong-Wei Gan; Frederick A Boop
Journal:  Childs Nerv Syst       Date:  2015-08-16       Impact factor: 1.475

Review 4.  Pediatric surgical neuro-oncology: current best care practices and strategies.

Authors:  James T Rutka; John S Kuo
Journal:  J Neurooncol       Date:  2004 Aug-Sep       Impact factor: 4.130

5.  Surgical management of tumors producing the thalamopeduncular syndrome of childhood.

Authors:  S Jared Broadway; Robert J Ogg; Matthew A Scoggins; Robert Sanford; Zoltan Patay; Frederick A Boop
Journal:  J Neurosurg Pediatr       Date:  2011-06       Impact factor: 2.375

6.  Variation of post-treatment H-MRSI choline intensity in pediatric gliomas.

Authors:  J A Lazareff; R K Gupta; J Alger
Journal:  J Neurooncol       Date:  1999-02       Impact factor: 4.130

7.  Diencephalic tumors in children: a 30-year experience of a single institution.

Authors:  Nalan Yazici; Ali Varan; Nejat Akalan; Figen Söylemezoğlu; Faruk Zorlu; Tezer Kutluk; Canan Akyüz; Münevver Büyükpamukçu
Journal:  Childs Nerv Syst       Date:  2011-02-25       Impact factor: 1.475

Review 8.  Current treatment of thalamic gliomas in children.

Authors:  M M Souweidane; H J Hoffman
Journal:  J Neurooncol       Date:  1996 May-Jun       Impact factor: 4.130

9.  Surgical management of thalamic gliomas: case selection, technical considerations, and review of literature.

Authors:  Narayanam Anantha Sai Kiran; Sumit Thakar; Ravi Dadlani; Dilip Mohan; Sunil Valentine Furtado; Nandita Ghosal; Saritha Aryan; Alangar S Hegde
Journal:  Neurosurg Rev       Date:  2013-01-25       Impact factor: 3.042

10.  The role of up-front radiation therapy for incompletely resected pediatric WHO grade II low-grade gliomas.

Authors:  Kavita K Mishra; Dev R Puri; Brian T Missett; Kathleen R Lamborn; Michael D Prados; Mitchel S Berger; Anuradha Banerjee; Nalin Gupta; William M Wara; Daphne A Haas-Kogan
Journal:  Neuro Oncol       Date:  2006-02-22       Impact factor: 12.300

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.